Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Orthofix Intl NV (NQ: OFIX )

15.77 +0.26 (+1.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 334,786
Open 15.75
Bid (Size) 15.66 (1)
Ask (Size) 25.23 (2)
Prev. Close 15.51
Today's Range 15.59 - 16.24
52wk Range 9.575 - 21.60
Shares Outstanding 36,544,297
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Orthofix to Report Second Quarter 2024 Financial Results
From Orthofix Medical Inc.
Via Business Wire
Orthofix Announces 510(k) Clearance and First Implant of Fitbone Transport and Lengthening System
From Orthofix Medical Inc.
Via Business Wire

Performance

YTD
+20.11%
+20.11%
1 Month
+25.06%
+25.06%
3 Month
+18.39%
+18.39%
6 Month
+15.53%
+15.53%
1 Year
-23.67%
-23.67%

More News

Read More
Michael Finegan Named Chair of the Orthofix Board of Directors
From Orthofix Medical Inc.
Via Business Wire
Aviva McPherron Joins Orthofix as President of Global Operations and Quality
From Orthofix Medical Inc.
Via Business Wire
Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer; Max Reinhardt Begins as President of Global Spine
From Orthofix Medical Inc.
Via Business Wire
Orthofix Names Max Reinhardt President of Global Spine Business
From Orthofix Medical Inc.
Via Business Wire
Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program
From Orthofix Medical Inc.
Via Business Wire
Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail
From Orthofix Medical Inc.
Via Business Wire
Datadog To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
OFIX Stock Earnings: Orthofix Medical Meets EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Orthofix Reports First Quarter 2024 Results
From Orthofix Medical Inc.
Via Business Wire
Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
From Orthofix Medical Inc.
Via Business Wire
Orthofix Names Andres Cedron as New Chief Legal Officer
From Orthofix Medical Inc.
Via Business Wire
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
From Orthofix Medical Inc.
Via Business Wire
OFIX Stock Earnings: Orthofix Medical Misses EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Orthofix Reports Fourth Quarter and Full Year 2023 Results
From Orthofix Medical Inc.
Via Business Wire
Orthofix Announces New President for Bone Growth Therapies Business
From Orthofix Medical Inc.
Via Business Wire
Earnings Scheduled For March 5, 2024
Via Benzinga
Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024
From Orthofix Medical Inc.
Via Business Wire
Orthofix Announces Commercial Partnership with MRIguidance
From Orthofix Medical Inc.
Via Business Wire
Julie Andrews Begins as New Chief Financial Officer at Orthofix
From Orthofix Medical Inc.
Via Business Wire
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
From Orthofix Medical Inc.
Via Business Wire
Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
From Orthofix Medical Inc.
Via Business Wire
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis
From Orthofix Medical Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.